Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Geneos Therapeutics

Request full access

Developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment

Whitemarsh Township, United StatesFounded 2018Biotech & Life Sciences

About Geneos Therapeutics

Geneos Therapeutics is a biotechnology company focused on developing personalized cancer immunotherapies. The company operates in the biotechnology and pharmaceutical market, serving clients such as research institutions, hospitals, and pharmaceutical companies. Geneos's core product is the GT EPICTM platform, which is designed to enhance the efficiency and effectiveness of clinical trials globally. This platform leverages advanced technologies to create personalized neoantigen-targeting vaccines, aiming to improve patient outcomes in oncology. The business model revolves around partnerships, licensing agreements, and direct sales of their proprietary technologies. Revenue is generated through these collaborations, clinical trial services, and the commercialization of their immunotherapy products.

Source: Dealroom company data

At a glance

Status
Operational
Employees
12
Open positions
None listed
Dealroom signal
74.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Sep 2023 $5M $85M SHC Shanghai Biomedical Fund ↗
SERIES A✓Equity / VC Apr 2023 $5M $85M 3B Future Health Fund ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Geneos Therapeutics website traffic

Latest recorded traffic for Geneos Therapeutics is 1.8K monthly website visits, up 102.2% over the last three months. Geneos Therapeutics's team grew 9.1% over the past year.

Latest monthly visits1.8K 3-month web change+102.2% 1-year team growth+9.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Geneos Therapeutics in the Whitemarsh Township ecosystem

Live from Dealroom

The Geneos Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A8 investors entered at this stage

  • Sante Ventures
  • Inovio Pharmaceuticals
  • Korea Investment Partners
  • Flerie Invest
  • Global Bio Fund
  • Ted Fjällman
  • 3B Future Health Fund
  • SHC Shanghai Biomedical Fund
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States88.9%
🏳️ Monaco11.1%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Geneos Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Geneos Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.